Advanced Rheumatology Course: All Activities
$239900
ADV-ALL-EXP25
Basic & Clinical Sciences, Infections & Related Arthritides, Lupus, Rheumatoid Arthritis
Wednesday, August 16, 2023, 1:00 AM
Saturday, August 15, 2026, 11:55 PM
CME, Participation
Advanced Practice Nurses, Counselors, Nurses, Occupational Therapists, Pharmacists, Practice Administrators, Primary Care Providers, Physical Therapists, Physician Assistants, Researchers, Residents
Advanced Rheumatology Course
25.00

Program Information

The Advanced Rheumatology Course (ARC) is a comprehensive, 19-module educational series geared toward members of the rheumatology interprofessional team and other professionals needing a deeper dive into rheumatology. Use the course to learn how to assess and manage patients with rheumatic disease, develop strategies to better integrate NP/PAs into rheumatology practice, and improve access to care for patients. The course has a strong focus on advanced information that will help experienced practice providers function well in rheumatology and foster interprofessional collaboration.

Target Audience

The course was created for nurse practitioners and physician assistants; however, rheumatology fellows-in training, internal medicine residents, medical students, primary care providers and other providers new to rheumatology may also benefit.

Learning Objectives

Upon completion of this course, participants should be able to do the following: 

  • Assess and manage patients with rheumatic diseases as part of an interprofessional collaborative care team.
  • Develop strategies to integrate the nurse practitioner and physician assistant into a collaborative rheumatology practice.
  • Assist in decreasing wait times for appointments and improve access to care for patients with rheumatic disease by improving the competence and performance of nurse practitioners and physician assistants in a collaborative rheumatology practice.


Advanced Rheumatology Activities


CME Information

Accreditation Statement

The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

The ACR designates this enduring material activity for a maximum of 25.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Health Professionals

Participants may claim hours to receive a Certificate of Participation for an activity designated for AMA PRA Category 1 Credits™.  By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board(s).

See the ACR's CME Mission Statement. For more information, download the AMA PRA Booklet.

Financial Relationships Disclosures

ACR Disclosure Statement

It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at http://accme.org .

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.

For this educational activity, all conflicts of interest have been resolved through peer review and revisions to ensure independence, evidence based, fair balance, and absence of commercial bias.

All individuals involved or able to influence the content of this accredited activity have disclosed to the editorial team and audience any/all financial or other relationship(s) including, but not limited to:

  1. Advisor or review panel member
  2. Consultant
  3. Employee
  4. Officer or Board Member
  5. Grant/research support
  6. Speaker/honoraria includes speaker’s bureau, symposia, and expert witness
  7. Independent contractor
  8. Executive role and/or ownership interest
  9. Royalties and/or patent beneficiary
  10. Intellectual property/patents
  11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan
  12. Private investigator
  13. Expert witness
  14. Equity interest
  15. Other: specify details

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

 

ARC01: Musculoskeletal Structure And Function And Inflammation And Immunity

Authors/Planners:

Kenneth S. O’Rourke, MD - No relevant financial relationships to disclose

Rachel M. Wolfe, MD - No relevant financial relationships to disclose

Content Reviewers Disclosures:

Daniel Schaffer, MD – No relevant financial relationships to disclose

Anneke Smith – No relevant financial relationships to disclose

Ben Smith, DMSc, PA-C, DFAAPA – No relevant financial relationships to disclose

 

ARC02: Framework for Clinical Decision Making in Rheumatology

Authors/Planners: 

Megan Lockwood, MD - No relevant financial relationships to disclose

Content Reviewers Disclosures:

Jennifer Grossman, MD - No relevant financial relationships to disclose

Anneke Smith – No relevant financial relationships to disclose

Sonam Kiwalkar, MD – No relevant financial relationships to disclose

 

ARC03:  Laboratory Evaluation of Rheumatic Disease

Authors/Planners:

Beth Jonas, MD – No relevant financial relationships to disclose

Content Reviewers Disclosures:

Laurie Hughell, MPH, PA-C - No relevant financial relationships to disclose 

Anneke Smith – No relevant financial relationships to disclose

Ben Smith, DMSc, PA-C, DFAAPA – No relevant financial relationships to disclose

 

ARC04: Imaging of Arthritis

Authors/Planners:

Beth Jonas, MD – No relevant financial relationships to disclose

Content Reviewers Disclosures:

Laurie Hughell, MPH, PA-C - No relevant financial relationships to disclose

Anneke Smith – No relevant financial relationships to disclose

Ben Smith, DMSc, PA-C, DFAAPA – No relevant financial relationships to disclose

 

ARC05: Coding And Practice Issues

Authors/Planners:

J. Eugene Huffstutter, MD - No relevant financial relationships to disclose

Content Reviewers Disclosures:

Fredrica Smith, MD - No relevant financial relationships to disclose

Julie Lahti - No relevant financial relationships to disclose

Ben Smith, DMSc, PA-C, DFAAPA - No relevant financial relationships to disclose

 

ARC06: Therapeutic Interventions And Resources

Authors/Planners:

Donna Everix, MPH, PT - No relevant financial relationships to disclose

Jennifer Trizuto, DPT - No relevant financial relationships to disclose

Content Reviewers Disclosures:

Marie Westby, PT, PhD - Janssen Canada5; Ended 2020; Pfizer5; Ended 2020

Julie Lahti - No relevant financial relationships to disclose

Ben Smith, DMSc, PA-C, DFAAPA - No relevant financial relationships to disclose

 

ARC07: Osteoarthritis

Authors/Planners:

Abhijeet Danve, MD – AbbVie/Abbott1; Novartis

Yuliya Afinogenova, MD - No relevant financial relationships to disclose 

Swetha Alexander, MD - No relevant financial relationships to disclose 

Content Reviewers Disclosures:

Janeth Yinh, MD – No relevant financial relationships to disclose 

Anneke Smith – No relevant financial relationships to disclose 

Sonam Kiwalkar, MD – No relevant financial relationships to disclose

 

ARC08: RA and Seronegative Inflammatory Arthropathies

Authors/Planners:

Gregory C. Gardner, MD, MACP – No relevant financial relationships to disclose

Content Reviewers Disclosures:

Sheila Arvikar, MD – No relevant financial relationships to disclose

Julie Lahti - No relevant financial relationships to disclose

Sonam Kiwalkar, MD – No relevant financial relationships to disclose

 

ARC09: Systemic Lupus Erythematosus

Authors/Planners:

Mary Chester Wasko, MD, AbbVie/Abbott2; AstraZeneca2; EMD Serono2; GlaxoSmithKlein2; HGS2; Roche2

Joanna Marco, MD – No relevant financial relationships to disclose

Content Reviewers Disclosures:

Paul Monach, MD, PhD – Celgene1; Chemocentryx6; Kiniksa16

Anneke Smith – No relevant financial relationships to disclose

Marcy Bolster, MD – AbbVie2; American Board of Internal Medicine: Chair, ABIM Rheumatology Board6; Amgen2; Corbus Pharmaceuticals2; Cumberland2; Genentech2; Gilead Sciences5; Johnson & Johnson1; Pfizer2

 

ARC10: Systemic Inflammatory Conditions

Authors/Planners:

Jason Kolfenbach, MD: ChemoCentryx

Tara Skorupa, MD: No relevant financial relationships to disclose

Content Reviewers Disclosures:

Zsuzsanna McMahon – No relevant financial relationships to disclose

Marcy Bolster, MD – AbbVie2; American Board of Internal Medicine: Chair, ABIM Rheumatology Board6; Amgen2; Corbus Pharmaceuticals2; Cumberland2; Genentech2; Gilead Sciences5; Johnson & Johnson1; Pfizer2

Julie Lahti – No relevant financial relationships to disclose

 

ARC11: Vasculitis, Arteritis and PMR

Authors/Planners:

Anisha Dua, MD - AbbVie/Abbott5, 8; ChemoCentryx5; Novartis5

Josh Waytz, MD – No relevant financial relationships to disclose

Content Reviewers Disclosures:

Paul Monach, MD, PhD – Celgene1; Chemocentryx6; Kiniksa

Anneke Smith – No relevant financial relationships to disclose

Marcy Bolster, MD – AbbVie2; American Board of Internal Medicine: Chair, ABIM Rheumatology Board6; Amgen2; Corbus Pharmaceuticals2; Cumberland2; Genentech2; Gilead Sciences5; Johnson & Johnson1; Pfizer2

 

ARC12:  Crystal-Induced Arthropathies

Authors/Planners:

Puja Khanna, MD – DYVE2; Horizon1,2,5; Select1,2

Content Reviewers Disclosures:

Chio Yokose, MD – No relevant financial relationships to disclose

Anneke Smith – No relevant financial relationships to disclose

Sonam Kiwalkar, MD – No relevant financial relationships to disclose

 

ARC13: Pain Syndromes

Authors/Planners:

Andrew Heisler, MD – No relevant financial relationships to disclose

Content Reviewers Disclosures:

Sonam Kiwalkar, MD – No relevant financial relationships to disclose

Christine Stamatos, DNP – No relevant financial relationships to disclose 

Julie Lahti – No relevant financial relationships to disclose

 

ARC14: Spondyloarthritis

Authors/Planners:

Atul Deodhar, MD -  AbbVie/Abbott528;  Amgen528;  BMS528;  Boheringer Ingelheim528;  Celgene528;  Gilead528;  Glapagos528;  Janssen528;  Lilly528;  Novartis528;  Pfizer528;  UCB528

Anand Kumthekar, MD – No relevant financial relationships to disclose

Content Reviewers Disclosures:

Abhijeet Danve, MD – AbbVie/Abbott1; Novartis1

Anneke Smith – No relevant financial relationships to disclose

Sonam Kiwalkar, MD – No relevant financial relationships to disclose

 

ARC15: Infection-Related Arthritis

Authors/Planners:

Robert A. Kalish, MD – No relevant financial relationships to disclose

Janet Hong, MD – No relevant financial relationships to disclose

Frank Scangarello, MD, PhD – No relevant financial relationships to disclose

Content Reviewers Disclosures:

Michael Battistone, MD – American Board of Internal Medicine Rheumatology Exam Committee6: Advisor or Review Panel member

Anneke Smith – No relevant financial relationships to disclose

Marcy Bolster, MD – AbbVie2; American Board of Internal Medicine: Chair, ABIM Rheumatology Board6; Amgen2; Corbus Pharmaceuticals2; Cumberland2; Genentech2; Gilead Sciences5; Johnson & Johnson1; Pfizer2

 

ARC16: Osteoporosis And Other Metabolic Bone Disorders

Authors/Planners:

Sarah Keller, MD – No relevant financial relationships to disclose

Content Reviewers Disclosures:

Alfred Denio, MD –  Abbvie8; Bristol-Myers Squibb5

Marcy Bolster, MD – AbbVie2; American Board of Internal Medicine: Chair, ABIM Rheumatology Board6; Amgen2; Corbus Pharmaceuticals2; Cumberland2; Genentech2; Gilead Sciences5; Johnson & Johnson1; Pfizer2

Julie Lahti – No relevant financial relationships to disclose

 

ARC17: Comprehensive Overview of Juvenile Idiopathic Arthritis (JIA)

Authors/Planners:

Betsy Roth-Wojcicki, RN, MS, CPNP-PC - No relevant financial relationships to disclose

Content Reviewers Disclosures:

Heather Benham, APRN, CPNP, DNP, RhMSUS – No relevant financial relationships to disclose

Anneke Smith - No relevant financial relationships to disclose

Ben Smith, DMSc, PA-C, DFAAPA – No relevant financial relationships to disclose

 

ARC18: Comprehensive Overview of Pediatric Connective Tissue Diseases (CTD)

Authors/Planners:

Heather Benham, DNP, APRN, CPNP-PC, RhMSUS – No relevant financial relationships to disclose

Content Reviewers Disclosures:

Natasha Ruth, MD, MS – No relevant financial relationships to disclose

Marcy Bolster, MD – AbbVie2; American Board of Internal Medicine: Chair, ABIM Rheumatology Board6; Amgen2; Corbus Pharmaceuticals2; Cumberland2; Genentech2; Gilead Sciences5; Johnson & Johnson1; Pfizer2

Julie Lahti – No relevant financial relationships to disclose

 

ARC19: Pediatric Noninflammatory Musculoskeletal Pain

Authors/Planners:

Bethany A. Marston, MD – No relevant financial relationships to disclose

Content Reviewers Disclosures:

Susan Shenoi, MS, MBBS, RhMSUS – Pfizer5

Julie Lahti - No relevant financial relationships to disclose

Sonam Kiwalkar, MD – No relevant financial relationships to disclose

*All of the relevant financial relationships listed for these individuals have been mitigated.

Aknowledgement of Corporate Support

The project described was supported by Grant number 1 NU58DP006908-03-00 – Component A; Developing and Disseminating Programs to Build Sustainable Lupus Awareness, Knowledge, Skills and Partnerships. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Department of Health and Human Services, Centers for Disease Control and Prevention.

Online Activity Refund Policy

  • Requests for cancellations and refunds must be received in writing to education@rheumatology.org within 24 hours of the online activity enrollment date.
  • Completed online activities are not eligible for a refund. 
  • Refunds will be subject to an administration fee per person and per activity: 15% for members; 30% for potential members.
  • Canceled online activities are nontransferable.

ARC01: Musculoskeletal Structure and Function and Inflammation and Immunity

Review the basic framework of the musculoskeletal system, in addition to exploring the key principles of immune system operation and autoimmunity.

ARC02: Framework for Clinical Decision Making in Rheumatology

Learn to generate comprehensive frameworks for clinical decision-making, which will enable you to effectively navigate your daily tasks in the rheumatology clinic.

ARC03: Laboratory Evaluation of Rheumatic Disease

Review laboratory tests for the evaluation, diagnosis, and treatment of the most prevalent rheumatologic conditions.

ARC04: Imaging of Arthritis

Learn about different imaging modalities to aid in diagnosing rheumatic disease and making informed decisions regarding the most suitable treatments for patients.

ARC05: Coding and Practice Issues

Explore the significance of accurate documentation and coding procedures in practice and ensuring the precision and suitability of reporting.

ARC06: Therapeutic Interventions and Resources

Dive into a comprehensive presentation on therapeutic interventions, featuring the expertise of both physical therapists and occupational therapists.

ARC07: Osteoarthritis

Learn how osteoarthritis adversely affects mobility, significantly contributes to disability rates, and imposes substantial a financial burden on society.

ARC08: RA and Seronegative Inflammatory Arthropathies

Review rheumatoid arthritis as well as seronegative inflammatory arthropathies, including how to distinguish between the three primary forms of joint pain.

ARC09: Systemic Lupus Erythematosus

Explore the various manifestations of lupus, effective methods for diagnosing the condition, and optimal approaches for managing patients with lupus.

ARC10: Systemic Inflammatory Conditions

Learn how to accurately diagnose, administer appropriate treatments, and establish care plans for patients with inflammatory myopathy, Sjögren’s disease, and systemic sclerosis.

ARC11: Vasculitis, Arteritis and PMR

Review the epidemiology, clinical features, differential diagnoses, treatment options, and outcomes concerning vasculitis and other vasculitides.

ARC12: Crystal-induced Arthropathies

Learn to recognize diverse clinical presentations, underlying causes, pertinent diagnostic examinations, and effective management strategies for crystal deposition disorders.

ARC13: Pain Syndromes

Increase your knowledge on pain syndromes for your patients with rheumatic disease and learn about delivering optimal patient care.

ARC14: Spondyloarthritis

Review spondyloarthritis, encompassing axial spondyloarthritis, psoriatic arthritis, reactive arthritis, and inflammatory bowel disease-associated arthritis.

ARC15: Infection-related Arthritis

Learn about infection-related arthritis and septic arthritis, along with its associated rheumatic manifestations, including those related to HIV.

ARC16: Osteoporosis and Other Metabolic Bone Disorders

Examine osteoporosis and other metabolic bone disorders and how to care for patients with these conditions.

ARC17: Comprehensive Overview of Juvenile Idiopathic Arthritis (JIA)

Review the knowledge and skills needed to effectively evaluate, treat, and support patients with juvenile idiopathic arthritis (JIA) and their families.

ARC18: Comprehensive Overview of Pediatric Connective Tissue Diseases (CTD)

Explore the necessary knowledge and skills to effectively evaluate, treat, and educate patients with pediatric connective tissue diseases and their families.

ARC19: Pediatric Noninflammatory Musculoskeletal Pain

Learn to distinguish between individuals who exhibit signs of inflammation and those experiencing non-inflammatory pain, and review its common patterns.